The hypoxia could modulate the expression of ACE-2 and syndecan-1 receptors, suggesting that low oxygen levels in COVID-19 patients are a defense mechanism to reduce the expression of entry receptors and attachment factors located in cholesterol-rich lipid rafts (136). Here, ACE2 is linked to COVID-19.